Cannoid was founded in 2013 from an R&D lab at the University of Colorado Health Sciences campus near Denver. In those early days, hemp extracts had to be imported (pre 2014 Farm Bill), and Cannoid was the first FDA-registered manufacturer to legally import CBD.
There was a limited commercial market for CBD products in 2013. Most finished goods were geared to the needs of customers referred by physicians, and our focus was on patients with severe degenerative neurologic conditions. Our initial formulations were backed by our basic research and observational studies on the extract and the active compounds inside: cannabinoids, terpenes, and flavonoids, as well as hemp seed oil and natural plant lipids.
Slowly the word got out that we were a "pivot point" for premium hemp extracts, oil formulation, and analytical testing. With the passage of the Farm Bill in 2014, an entirely new customer base emerged for us: extractors and brand-builders that needed custom CBD products built to spec. We immediately got very busy making tinctures, softgels, vapes, and topicals for the industry. At this point we also established a robust quality management system that is still the backbone of our facility 9 years later.
In 2018 we made significant upgrades to our facilities and manufacturing capacities. We moved into a 12,000 sq ft building in Denver and built it out to accommodate our rapid growth in the softgel category. We added 5,000 sq ft of new clean room space specifically for formulation and manufacturing, and we added a much larger softgel encapsulation line. We then added our pharmaceutical blister pack machines and additional laboratory capacity and instrumentation to create oil emulsions and suspensions (homogenization and sonication).
We see ourselves as a turnkey lab for cannabinoid softgels. We can handle any cannabinoid specification, and with our deep experience and passion for the cannabis plant, we constantly find ways to help our clients avoid the entanglements and pitfalls common to the CBD space.